Welcome to our dedicated page for Quanex Build SEC filings (Ticker: NX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quanex Building Products Corporation filings document the financial reporting, governance and capital-allocation disclosures of a global building-products manufacturer. Its 8-K reports cover operating results, non-GAAP financial measures, liquidity under its senior secured revolving credit facility, and Regulation FD notices for common-stock dividends.
Quanex’s proxy materials and governance filings record annual meeting proposals, director elections, executive-compensation votes, auditor ratification, bylaw amendments, stockholder nomination procedures, remote-meeting authority, universal proxy rule provisions, independent auditor changes, and board observer-right matters.
Quanex Building Products Corp executive Paul B. Cornett, SVP General Counsel and Secretary, reported equity transactions in company common stock. On December 4, 2025, he acquired 13,100 shares of common stock at $0, increasing his direct holdings. On December 7, 2025, he disposed of 1,778 shares at $13.85 per share in a transaction coded “F,” meaning shares were sold to cover taxes due on the lapse of forfeiture restrictions tied to restricted stock originally granted on December 7, 2022. After these transactions, he directly owned 69,995.6094 shares of Quanex common stock, which includes 74.1871 shares credited from prior dividend reinvestments under the company’s Employee Stock Purchase Plan.
Quanex Building Products Corporation reported that its Board of Directors has declared a regular quarterly cash dividend. The dividend is set at $0.08 per share on the company’s common stock. It will be paid on December 31, 2025 to shareholders who are on record as of December 15, 2025. This announcement continues the company’s practice of returning cash to shareholders through recurring dividends.
Quanex Building Products (NX) executive VP - Operations Excellence reported small stock purchases under the company’s Employee Stock Purchase Plan on a Form 5 for the fiscal year ended 10/31/2025. The reporting person acquired modest amounts of common stock in monthly transactions from 04/02/2025 through 10/02/2025, at prices ranging from $14.42 to $20.78, all coded as exempt acquisitions under Rule 16b-3.
After these transactions, the executive beneficially owned 2,522.0789 shares of Quanex common stock directly. This total includes fractional shares credited from dividend reinvestments, specifically 0.2734 shares and 1.0789 shares added to the account through the Employee Stock Purchase Plan’s dividend reinvestment feature.
Quanex Building Products (NX) reported a Form 4 showing a director received 8,045 restricted stock units (RSUs) on 11/03/2025. Each RSU represents a right to receive cash equal to the value of one share of Quanex common stock.
The RSUs vest immediately and become payable upon the grantee’s death, disability, cessation of service as a director, or a change in control of the company. Following the transaction, the reporting person beneficially owned 29,368 derivative securities, held directly.
Quanex Building Products (NX) reported a director’s equity award on Form 4. The filing shows the grant of 8,045 restricted stock units on 11/03/2025.
The RSUs vest immediately and represent a right to receive cash equal to the value of one share of Quanex common stock. Payment occurs upon death, disability, the director’s cessation of service, or a change of control.
After this transaction, the director beneficially owned 12,308 derivative securities, held directly.
Quanex Building Products (NX) reported a director equity transaction. On 11/04/2025, the director acquired 8,045 restricted stock units (RSUs) at $0 per unit. Each RSU represents a contingent right to receive cash equal to the value of one share of Quanex common stock. The RSUs vest immediately and become payable upon the grantee’s death, disability, cessation of service as a director, or a change in control of the company. Following the transaction, the director reported 36,509 derivative securities held directly.
Quanex Building Products (NX) reported a director equity grant on a Form 4. On 11/03/2025, the director acquired 8,045 restricted stock units at $0. These RSUs vest immediately and each represents a right to receive cash equal to the value of one share, payable upon death, disability, end of board service, or a change in control. Following the transaction, derivative securities beneficially owned were 24,955, held directly.
Quanex Building Products (NX) reported an insider equity grant. A director acquired 8,045 restricted stock units on 11/03/2025 (Transaction Code A).
The RSUs vest immediately and will pay out on the earlier of the third anniversary of grant or upon the director’s death, disability, cessation of service, or a change in control. Following the grant, the director directly beneficially owns 23,248 derivative securities. The derivative price is listed as $0.
Quanex Building Products (NX) director reported the grant of 8,045 Restricted Stock Units on November 3, 2025 (Transaction Code A). Each RSU represents a contingent right to receive cash equal to the value of one share of Quanex common stock.
The RSUs vest immediately and pay out upon death, disability, cessation of service as a director, or change in control. Following the grant, the reporting person beneficially owned 12,308 derivative securities, held directly, at a stated price of $0 per unit.
Quanex Building Products (NX) reported an insider equity award. A company director acquired 8,045 restricted stock units on 11/03/2025 as disclosed on Form 4 Table II. Each RSU represents a contingent right to receive cash equal to the value of one share of Quanex common stock.
The RSUs vest immediately and will pay out upon the director’s death, disability, cessation of board service, or a change in control. Following the transaction, the director beneficially owned 8,045 derivative securities, held directly.